Evidence map›Paper›PMID 30681215›Full record

ArticleAddiction (Abingdon, England)2019

Prevalence of awareness, ever-use and current use of nicotine vaping products (NVPs) among adult current smokers and ex-smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross-sectional findings from the ITC Project.

Shannon Gravely, Pete Driezen, Janine Ouimet, Anne C K Quah, K Michael Cummings, Mary E Thompson, Christian Boudreau, David Hammond, Ann McNeill, Ron Borland and 15 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04982978 (The Effectiveness of the Protection Motivation Theory in Reducing Vaping Behaviour in a Student Population), which is not on this map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04982978 nacompletednot on this mapstarted 2021, after this paper: background citation

The Effectiveness of the Protection Motivation Theory in Reducing Vaping Behaviour in a Student Population

TypeinterventionalSponsorWestern UniversityRan2021 to 2021Enrolled77ConditionsVaping Related DisorderArmsPMT Threat Appraisal, General Nutrition and Lifestyle
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  9. Article
  10. Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 18 institutions in 14 countries.

Shannon GravelyUniversity of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0001-5224-9105
Pete DriezenUniversity of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0003-2320-0999
Janine OuimetUniversity of Waterloo, Waterloo, Ontario, Canada.
Anne C K QuahUniversity of Waterloo, Waterloo, Ontario, Canada.
K Michael CummingsMedical University of South Carolina, Charleston, SC, USA.
Mary E ThompsonUniversity of Waterloo, Waterloo, Ontario, Canada.
Christian BoudreauUniversity of Waterloo, Waterloo, Ontario, Canada.
David HammondUniversity of Waterloo, Waterloo, Ontario, Canada.
Ann McNeillAddictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID 0000-0002-6223-4000
Ron BorlandCancer Council Victoria, Melbourne, Australia.ORCID 0000-0003-0059-178X
James F ThrasherNational Institute of Public Health, Cuernavaca, Morelos, Mexico.
Richard EdwardsUniversity of Otago, Wellington, New Zealand.
Maizurah OmarUniversity Sains Malaysia, Penang, Malaysia.
Sara C HitchmanDeakin University, Geelong, Victoria, Australia.
Hua-Hie YongCancer Council Victoria, Melbourne, Australia.ORCID 0000-0001-8167-6173
Tonatiuh Barrientos-GutierrezNational Institute of Public Health, Cuernavaca, Morelos, Mexico.
Marc C WillemsenMaastricht University, Maastricht, the Netherlands.
Eduardo BiancoCentro de Investigación para la Epidemia del Tabaquismo, Montevideo, Uruguay.
Marcelo BoadoUniversidad de la República, Montevideo, Uruguay.
Fastone Mathew GomaUniversity of Zambia, Lusaka, Zambia.
Hong Gwan SeoNational Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
Nigar NargisAmerican Cancer Society, Washington, DC, USA.ORCID 0000-0003-4501-1398
Yuan JiangChinese Center for Disease Control and Prevention (China CDC), Beijing, China.
Cristina De Abreu PerezBrazil Cancer Foundation, Rio de Janeiro, Brazil.
Geoffrey T FongUniversity of Waterloo, Waterloo, Ontario, Canada.
University of Waterloo · CADeakin University · AUAmerican Cancer Society · USArnold Ventures · USCancer Council Victoria · AUCentro Uruguayo de Imagenología Molecular · UYChinese Center For Disease Control and Prevention · CNHospital do Câncer III · BRMaastricht University · NLMedical University of South Carolina · USNational Cancer Center · KRNational Institute of Public Health · SIOntario Institute for Cancer Research · CAUniversidad de la República de Uruguay · UYUniversiti Sains Malaysia · MYUniversity of Nottingham · GBUniversity of Otago · NZUniversity of Zambia · ZM

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEVY, DAVID THEODORE · 2016 to 2025
$25.3M
Variation in Cigarettes, Tobacco use Behaviors and Exposures in ITC CountriesP01CA138389 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI THOMPSON, MARY · 2009 to 2013
$13.4M
Electronic cigarettes in Latin America: Evaluation of impacts and policy optionsR01TW010652 · FIC · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BARNOYA, JOAQUIN, THRASHER, JAMES · 2018 to 2021
$1.6M
Brazil Fundação do Câncer BR/LOA/1500048.001Canadian Cancer SocietyChinese Centre for Disease Control and PreventionChinese Centre for Disease Control and Prevention, the Health Research Council of New Zealand GA215F 15/072CIHR FDN 148477CIHR MOP 115016Dutch Cancer Foundation UM 2014-7210FIC NIH HHS R01 TW010652Health Research Council of New Zealand GA215F 15/072Korean Ministry of Health and WelfareKorean Ministry of Health and Welfare, the Dutch Cancer Foundation (KWF) UM 2014-7210Medical Research Council MR/K023195/1Mexican Consejo Nacional de Ciencia y Tecnología Salud-2007-C01-70032 and Salud-2013-01-202671National Cancer Institute of BrazilNational Cancer Institute of Brazil (INCA), Pan-American Health Organization (PAHO), Brazil Fundação do Câncer BR/LOA/1500048.001National Health and Medical Research Council of Australia APP1106451NCI NIH HHS P01 CA138389NCI NIH HHS P01 CA200512Pan-American Health Organization (PAHO)
6 · The paper itself

Abstract

aimsThis paper presents updated prevalence estimates of awareness, ever-use, and current use of nicotine vaping products (NVPs) from 14 International Tobacco Control Policy Evaluation Project (ITC Project) countries that have varying regulations governing NVP sales and marketing. DESIGN, SETTING, PARTICIPANTS AND MEASUREMENTS: A cross-sectional analysis of adult (≥ 18 years) current smokers and ex-smokers from 14 countries participating in the ITC Project. Data from the most recent survey questionnaire for each country were included, which spanned the period 2013-17. Countries were categorized into four groups based on regulations governing NVP sales and marketing (allowable or not), and level of enforcement (strict or weak where NVPs are not permitted to be sold): (1) most restrictive policies (MRPs), not legal to be sold or marketed with strict enforcement: Australia, Brazil, Uruguay; (2) restrictive policies (RPs), not approved for sale or marketing with weak enforcement: Canada, Malaysia, Mexico, New Zealand; (3) less restrictive policies (LRPs), legal to be sold and marketed with regulations: England, the Netherlands, Republic of Korea, United States; and (4) no regulatory policies (NRPs), Bangladesh, China, Zambia. Countries were also grouped by World Bank Income Classifications. Country-specific weighted logistic regression models estimated adjusted NVP prevalence estimates for: awareness, ever/current use, and frequency of use (daily versus non-daily).

findingsNVP awareness and use were lowest in NRP countries. Generally, ever- and current use of NVPs were lower in MRP countries (ever-use = 7.1-48.9%; current use = 0.3-3.5%) relative to LRP countries (ever-use = 38.9-66.6%; current use = 5.5-17.2%) and RP countries (ever-use = 10.0-62.4%; current use = 1.4-15.5%). NVP use was highest among high-income countries, followed by upper-middle-income countries, and then by lower-middle-income countries.

conclusionsWith a few exceptions, awareness and use of nicotine vaping products varied by the strength of national regulations governing nicotine vaping product sales/marketing, and by country income. In countries with no regulatory policies, use rates were very low, suggesting that there was little availability, marketing and/or interest in nicotine vaping products in these countries where smoking populations are predominantly poorer. The higher awareness and use of nicotine vaping products in high income countries with moderately (e.g. Canada, New Zealand) and less (e.g. England, United States) restrictive policies, is likely due to the greater availability and affordability of nicotine vaping products.

Indexed as

Electronic Nicotine Delivery SystemsHealth Knowledge, Attitudes, PracticeAdultAustraliaBangladeshBrazilCanadaChinaCommerceCross-Sectional StudiesEnglandEx-SmokersFemaleHumansLogistic ModelsMalaysiaE-cigarettesglobalincome classificationnicotine vaping products (NVPs); smoking; international; regulationspoliciessurvey

Identifiers

PMID30681215
PMCPMC6510648
OpenAlexW2912904794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.